Dermal filler
Non-surgical nose reshaping
Filler can camouflage a dorsal hump, straighten a profile, lift a drooping tip and improve the angle between nose and lip. It works, it is quick, and it has almost no visible downtime.
It is also the highest-risk filler treatment in the published literature, and this page says so before it says anything else.
The numbers
From a review of 37 studies covering 8,604 patients:
| Complication | Rate |
|---|---|
| Overall complications | 2.52% |
| Bruising | 1.58% |
| Temporary vessel blockage | 0.35% |
| Vision loss | 0.09% |
| Skin death | 0.08% |
| Infection | 0.07% |
A 2024 review put serious vascular complications as high as 0.27%. In the largest review of filler-related blindness — 511 published cases — the nose accounts for the largest share of all cases. Of those reporting an outcome, 68% had no recovery of vision at all, and none of the standard treatments was reliably associated with improvement.
Low downtime does not mean low risk. This treatment is often sold as a lunchtime procedure. The recovery genuinely is quick. The risk is the highest on our list.
What it can and cannot do
It adds volume. It cannot make a nose smaller. If you want reduction, you want a surgeon, and we will tell you so.
Volume
0.3ml to 0.8ml. Very small amounts. Anything approaching a full millilitre in a first nasal treatment should worry you, wherever you are having it done.
Patient selection
We are strict about who we treat here, and we decline more often than for any other filler treatment. We do not treat anyone who has had surgical rhinoplasty or other nasal surgery — surgery alters the anatomy, and scarring can hold vessels in place.
We also decline where the nasal skin is very thin or scarred, where the goal is reduction, and where someone is unwilling to accept blindness as a disclosed risk.
Downtime
Minimal — swelling for one to three days, and bruising is uncommon.
Review
A free review at six weeks.